GPER1 promotes tumor progression mainly by interacting with carcinogenic signaling pathways, such as the EGFR/ERK1/2 pathway, the PI3K/AKT/mTOR signaling pathway, and the MAPK/ERK signaling pathway. This evidence concerns the gene MAPK3 and neoplasm.